Esperion reveals robust Q1 growth, FDA approval boosts By Investing.com
Esperion Therapeutics Inc. (NASDAQ:) has reported a significant surge in its first-quarter revenue for 2024, with a total revenue of ...
Esperion Therapeutics Inc. (NASDAQ:) has reported a significant surge in its first-quarter revenue for 2024, with a total revenue of ...
Ron Paul Trashes Speaker Mike Johnson in Stunning New Monologue “Senate Majority Leader Chuck Schumer is reported to have bragged ...
Bitcoin gained on Monday, adding 3% after dropping to as low as $61,300 over the weekend. The weekend’s drop was ...
By Suzanne McGee (Reuters) - Cboe Global Markets (NYSE:) filed a request with the SEC for regulatory approval to change ...
London-based ThinkSono, a medtech company specialising in ultrasound AI guidance solutions, has concluded its latest funding round, surpassing its target ...
On March 6, 2024, the US Securities and Exchange Commission (SEC) convened a meeting with representatives from Coinbase and Grayscale ...
© Reuters. The logo of the ANZ Banking Group is displayed in the window of a newly opened branch in ...
Grayscale CEO Michael Sonnenshein urged regulators to approve spot Bitcoin exchange-traded fund (ETF) options in a statement on Feb. 5.Sonnenshein ...
In October 2023, International Flavours and Fragrance (IFF), dsf-firmenich and local milk player Mengniu received approval for use of their ...
The Securities and Exchange Commission (SEC) has revealed that the unauthorized post about approving spot Bitcoin exchange-traded funds (ETFs) on ...